Bone tissue undergoes constant turnover supported by stem cells. Recent studies showed that perivascular mesenchymal stem cells (MSCs) contribute to the turnover of long bones. Craniofacial bones are flat bones derived from a different embryonic origin than the long bones. The identity and regulating niche for craniofacial-bone MSCs remain unknown. Here, we identify Gli1+ cells within the suture mesenchyme as the main MSC population for craniofacial bones. They are not associated with vasculature, give rise to all craniofacial bones in the adult and are activated during injury repair. Gli1+ cells are typical MSCs in vitro. Ablation of Gli1+ cells leads to craniosynostosis and arrest of skull growth, indicating that these cells are an indispensable stem cell population. Twist1 +/− mice with craniosynostosis show reduced Gli1+ MSCs in sutures, suggesting that craniosynostosis may result from diminished suture stem cells. Our study indicates that craniofacial sutures provide a unique niche for MSCs for craniofacial bone homeostasis and repair.
Bone tissue undergoes constant turnover supported by stem cells. Recent studies showed that perivascular mesenchymal stem cells (MSCs) contribute to the turnover of long bones. Craniofacial bones are flat bones derived from a different embryonic origin than the long bones. The identity and regulating niche for craniofacial-bone MSCs remain unknown. Here, we identify Gli1+ cells within the suture mesenchyme as the main MSC population for craniofacial bones. They are not associated with vasculature, give rise to all craniofacial bones in the adult and are activated during injury repair. Gli1+ cells are typical MSCs in vitro. Ablation of Gli1+ cells leads to craniosynostosis and arrest of skull growth, indicating that these cells are an indispensable stem cell population. Twist1
+/− mice with craniosynostosis show reduced Gli1+ MSCs in sutures, suggesting that craniosynostosis may result from diminished suture stem cells. Our study indicates that craniofacial sutures provide a unique niche for MSCs for craniofacial bone homeostasis and repair.
Craniofacial bones differ from the long bones. They are flat bones formed mainly through intramembranous rather than endochondral ossification and develop from embryological origins distinct from those of the long bones [1] [2] [3] . Perivascular MSCs have been identified in the bone marrow of the long bones and support their turnover and injury repair [4] [5] [6] [7] . Craniofacial bones contain little bone marrow space and are sheathed by periosteum and endosteum or dura 8, 9 . Although the question of whether there is a specific stem cell population in adult craniofacial bones has remained unanswered, it was generally assumed that these flat bones share the same turnover and injury repair mechanisms as long bones. It has been proposed that the periosteum contains progenitors that support craniofacial bone repair [10] [11] [12] [13] . The joints between craniofacial bones are known as sutures and are composed of two osteogenic fronts with suture mesenchyme between them ( Supplementary Fig. 1 ). Most sutures in mice remain patent throughout the animal's lifetime. In humans, cranial sutures normally fuse between 20 and 30 years of age and facial sutures fuse after 50 years of age 14, 15 . Craniosynostosis is a common congenital disorder characterized by premature cranial suture fusion, which may lead to severe outcomes including increased intracranial pressure, craniofacial dysmorphism, disrupted neurodevelopment, and mental retardation. Craniosynostosis is generally considered a developmental disorder resulting from a disrupted balance of cellular proliferation, differentiation and apoptosis within the suture [15] [16] [17] [18] [19] . Surgical removal of the affected suture followed by re-shaping of the calvarial bones remains the only treatment available for craniosynostosis patients [20] [21] [22] . Although the purpose of the surgery is to form artificial suturelike space between the calvarial bones to allow for brain expansion, the natural suture tissue is treated as surgical waste and routinely discarded during the procedure [23] [24] [25] . In our current study, using mouse craniofacial bones as a model, we identified Gli1+ cells within the suture mesenchyme as the main stem cell population for adult craniofacial bones. They give rise to the periosteum and dura. They are typical MSCs in vitro but are not associated with vasculature and are regulated by IHH secreted from the committed osteogenic progenitors. Ablation of Gli1+ cells in the adult mouse leads to craniosynostosis, skull growth arrest and osteoporosis. The Gli1+ cell population was diminished in craniosynostosis model Twist1 +/− mutant mice, which suggests that compromised stem cells might be the cause of craniosynostosis. Our finding indicates that a different niche regulates the stem cells of craniofacial bones from that of long bones. Craniosynostosis, a severe congenital disease, might be caused by stem cell population defects.
RESULTS
Gli1+ cells are specifically distributed in the suture mesenchyme of adult craniofacial bones We reasoned that Gli1+ cells are MSCs for craniofacial bones, as they are for the incisor mesenchyme 26 . First, we investigated the expression of Gli1 in mouse calvarial bones. At postnatal day 0 (P0), of calvarial bones of newborn (P0), 7-, 14-and 21-day-old (P7, P14, P21) and one-and three-month-old Gli1-LacZ mice. (g-i) LacZ staining of sections of sagittal sutures and parietal bones of P0, P7 and P14 mice indicates that Gli1+ cells are present in the suture mesenchyme (asterisks), periosteum (arrows) and dura (arrowheads). (j-l) LacZ staining of sections of the sagittal suture of one-month-old Gli1-LacZ mice. Asterisk indicates exclusive Gli1 expression within the suture mesenchyme. No positive staining is detectable in the periosteum (white arrow) and dura (white arrowhead). Outlined areas in j are shown in k and l. (m-p) LacZ staining of the mid-suture mesenchyme in the coronal (m), interpalatal (n), presphenoid-palatal (o) and maxillapalatal (p) sutures of one-month-old Gli1-LacZ mice. (q-t) ALPase (blue) and immunohistochemical (red) staining of sagittal sutures of one-month-old mice. Osteogenic markers including ALPase (q), Sp7 (r), osteocalcin (OC) (s) and Runx2 (t) are not detectable in the suture mesenchyme (asterisks). The periosteum (arrows) and dura (arrowheads) strongly express these markers. Outlined areas in r and t are enlarged in r and t , respectively, showing positive expression in the osteogenic fronts (arrowheads). Dotted lines outline margins of craniofacial bones. Scale bars in a-f, 1 mm; other scale bars, 100 µm.
Gli1+ cells are detectable throughout the entire periosteum, dura and suture mesenchyme, but not in the fontanelles or osteocytes (Fig. 1a,g ). A similar distribution pattern was detectable at P7 and P14 (Fig. 1b,c,h,i) . Between P21 and 1 month postnatally, Gli1+ cells are gradually restricted to the suture region (Fig. 1d,e) . At one month of age, Gli1+ cells are detectable only within the suture mesenchyme, mostly in the mid-suture region, but are absent from the periosteum, dura and osteocytes ( Fig. 1j-l) . Such a suture-specific pattern was also detectable in mice at three months of age and older (Fig. 1f) .
We next investigated the Gli1+ cell distribution pattern in other craniofacial sutures. In Gli1-LacZ mice at one month of age, we detected Gli1+ cells in the mesenchyme of most craniofacial sutures, including the coronal (Fig. 1m) , interpalatal (Fig. 1n) , presphenoidpalatal (Fig. 1o) , maxilla-palatal (Fig. 1p) , lambdoid ( Supplementary  Fig. 2a ), interparietal-occipital ( Supplementary Fig. 2b ), parietalsquamous ( Supplementary Fig. 2c ), maxilla-zygomatic (Supplementary Fig. 2d ), squamous-zygomatic ( Supplementary Fig. 2e ), maxilla-premaxilla ( Supplementary Fig. 2f ), frontal-maxilla (Supplementary Fig. 2g ), frontal-squamous ( Supplementary Fig. 2h ), frontal-premaxilla ( Supplementary Fig. 2i ), nasal-frontal (Supplementary Fig. 2j), intermaxilla (Supplementary Fig. 2k ), basosphenoidsquamous ( Supplementary Fig. 2l ) and basosphenoid-frontal (Supplementary Fig. 2m) sutures. Gli1+ cells are mainly present in the midsuture mesenchyme and are absent from the periosteum, dura and bones abutting the sutures. Interestingly, Gli1+ cells are not detectable in the posterior frontal suture mesenchyme at either P8 or P30. The posterior frontal suture is the only suture in the mouse that fuses around two weeks after birth [27] [28] [29] .
Craniofacial bones contain little bone marrow space compared with long bones. Gli1+ cells are also detectable on the inner surface of some bone marrow spaces ( Supplementary Fig. 4a ). The number of these bone marrow Gli1+ cells differs by location, but comprises only a minor population in craniofacial bones ( Supplementary Fig. 4b ).
To investigate the differentiation status of suture Gli1+ cells, we evaluated the expression of various osteogenic differentiation markers in the calvarial bones of one-month-old mice. All of the markers we tested, including ALPase, Sp7, Runx2 and osteocalcin, are strongly expressed in the periosteum and the dura, but are absent from most of the suture mesenchyme ( Fig. 1q-t) . Within the suture, Sp7 and Runx2 are expressed in a few cells within the osteogenic fronts, which are thin layers of cells immediately lining the bony surface (Fig. 1r ,t ) . Costaining indicates that Gli1+ cells are located near, but not within, the osteogenic fronts ( Supplementary Fig. 2n ).
Gli1+ cells in the suture mesenchyme give rise to osteogenic fronts, periosteum and dura To investigate whether Gli1+ cells in the suture mesenchyme are stem cells, we performed lineage tracing analysis. Gli1-Cre ERT 2 ;R26-ZsGreen flox or Gli1-Cre ERT 2 ;R26-tdTomato flox mice (Gli1-CE) were induced with tamoxifen at 1 month of age. Five days after induction, fluorescently labelled cells were detectable exclusively in the midsuture mesenchyme of the calvaria (Fig. 2a) and other craniofacial bones ( Fig. 2e and Supplementary Fig. 3a-m) , faithfully reproducing the Gli1+ cell distribution pattern. No signal was detectable in the osteogenic fronts ( Supplementary Fig. 3n ), periosteum, dura or osteocytes of craniofacial bones. One month later, we detected fluorescently labelled cells in the entire suture mesenchyme including the osteogenic fronts ( Supplementary Fig. 3n ,o ) , part of the periosteum, dura and a few osteocytes next to the osteogenic fronts of calvarial bones (Fig. 2b) . Examination of other craniofacial sutures including the sutures in the basal skull region and facial region indicated that significant numbers of cells in the periosteum and bones were already strongly labelled with fluorescence one month after induction ( Supplementary Fig. 3a -m ) . The presence of Gli1+ cells in these structures can be attributed to both the postnatal growth of the skull vault and the postnatal turnover of craniofacial bones. The turnover rates of different craniofacial bones vary significantly and calvarial bones turn over much slower than other craniofacial bones.
Two months after induction, the entire suture mesenchyme, periosteum and dura as well as parts of the calvarial bones were strongly labelled (Fig. 2c) . Most of the labelled calvarial osteocytes were located either next to the suture or peripherally, indicating that new bone deposits mostly at the osteogenic front region and external surface of the calvarial bones. Eight months after induction, the entire calvaria including the suture mesenchyme, periosteum, dura and almost every osteocyte were strongly labelled, suggesting a complete turnover of calvarial bone within this time period (Fig. 2d) .
Gli1+ cells in the bone marrow also give rise to osteocytes immediately surrounding the bone marrow space, but not to blood cells ( Supplementary Fig. 4c,d ). Their contribution to craniofacial bones is limited owing to the small percentage of Gli1+ cells in the bone marrow space.
Gli1+ cells contribute to injury repair and transplant growth
Gli1+ cells in the suture mesenchyme normally do not undergo active division. However, within 24 h after an injury, they can be rapidly activated into proliferation (Fig. 3a,b) . To investigate the contribution of Gli1+ cells to injury repair, we induced Gli1-CE mice with tamoxifen at one month of age and made an injury to the calvarial bone. Two weeks after injury, most of the cells within the injured region were strongly labelled, indicating their derivation from Gli1+ cells (Fig. 3c) . One month after injury, the periosteum, dura and many osteocytes in the repair region were strongly labelled, indicating that Gli1+ cells contribute to post-injury repair of the calvarial bone (Fig. 3d) .
Previously, it was proposed that progenitor cells supporting craniofacial bone repair mainly reside in the periosteum. Our lineage tracing analysis indicated that, instead, the suture mesenchyme gives rise to the periosteum and dura during natural turnover. To confirm this relationship, we induced Gli1-CE mice at one month of age. After removing the periosteum and dura, we transplanted a piece of calvarial bone containing the sagittal suture into nude mice. Only the suture mesenchyme was labelled in samples collected 72 h after transplantation (Fig. 3e) . One week after transplantation, newly generated, fluorescently labelled periosteum and dura were detectable on the surfaces of the transplants (Fig. 3f) . One month after transplantation, the suture transplants merged with the host bone. A significant number of cells within the periosteum, dura and bone (osteocytes) of the transplant were strongly labelled, indicating their derivation from the Gli1+ cells within the suture mesenchyme (Fig. 3g) . Calvarial bones not containing any suture taken from the same donor mice were also transplanted as controls (Fig. 3h) . Although Gli1+ cells in the bone marrow space survived one month after transplantation, they failed to generate new periosteum, dura or osteocytes. Therefore, bone marrow Gli1+ cells are either unable or insufficient to support efficient repair or regeneration.
To evaluate the regeneration ability of suture tissue and specifically to compare it with the periosteum, we transplanted calvarial bones with or without suture from CMV-EGFP mice of one month of age into nude mice. The suture transplants grew rapidly and doubled their surface area within one month, whereas the control calvarial bone transplants without sutures failed to grow even though they contained (e-i) Five days (e,a ) and one month (f-i) after induction, fluorescently labelled cells are detectable in the craniofacial sutures (low-magnification image in e) including the squamous-presphenoid (e ,f), presphenoidpalatal (e ,g), interpalatal (e ,h) and maxilla-palatal (e ,i) sutures. Dotted lines outline craniofacial bones. Scale bars in a-d, 1 mm; other scale bars, 100 µm.
intact periosteum and dura (Fig. 3i,j) . This result indicates the suture tissue possesses regenerative capacity but periosteum and dura do not, consistent with a previous suture transplantation study 30 .
Gli1+ cells are typical MSCs in vitro
The current definition of MSCs is based on in vitro assays. Therefore, we evaluated Gli1+ cells in accordance with these standards. Immunohistochemical staining indicated that most Gli1+ cells in the suture mesenchyme do not express MSC markers including CD90, CD73, CD44, Sca1 and CD146 ( Fig. 4a-f ). CD44 expression was detectable in the osteogenic front region (Fig. 4c) , and Sca1 expression was detectable in the periosteum (Fig. 4f ). To study their in vitro properties, Gli1-Cre ERT 2 ;R26-tdTomato flox mice at 1 month of age were induced with tamoxifen. Mesenchymal cells were obtained from the suture one week after induction and cultured. Fluorescence-activated cell sorting (FACS) analysis indicated that Gli1+ cells and their derivatives express high levels of typical MSC markers including CD44, CD90, Sca1, CD146 and CD73, but not CD34 (Fig. 4g ). Clonal culture indicated that Gli1+ cells possess clone-forming ability (Fig. 4h,k) . Subculture of clones indicated that clones derived from single Gli1+ cells are capable of osteogenic, chondrogenic and adipogenic differentiation (Fig. 4i-l) and are therefore multipotent 31 . We compared the differentiation ability of suture MSCs with MSCs taken from femur bone marrow of the same mice. Although the osteogenic and chondrogenic differentiation abilities were comparable, the adipogenic differentiation ability of the suture MSCs was much weaker than that of the bone marrow MSCs (Fig. 4m) . These data indicate that although Gli1+ cells do not express MSC markers in vivo, they behave like typical MSCs in vitro and are more committed towards osteochondrogenic lineages. Traditional MSC markers routinely used to identify MSCs in vitro are not ideal markers for MSCs in vivo.
Gli1+ stem cells are not associated with vasculature in the suture mesenchyme and are regulated by IHH from the osteogenic front Previous studies have proposed that MSCs in the long bone are regulated by a perivascular niche 4 . We therefore set out to determine whether Gli1+ cells in the suture are regulated by the same mechanism. In fact, we found that Gli1+ cells in the suture mesenchyme mainly reside around the midline of the structure and do not show a particular affinity for the vasculature (Fig. 5a ). After induction, Shh-Cre ERT 2 ;R26-tdTomato flox mice do not show any signal in the suture region (Fig. 5b) , indicating the absence of SHH from the suture mesenchyme, consistent with a previous study 32 . However, IhhLacZ reporter mice revealed Ihh+ cells lining the edges of the calvarial bones (Fig. 5c,d ). Ihh+ cells are positive for Sp7 and Runx2 (Fig. 5e,f) and therefore can be deemed to reside within the osteogenic front in cranial sutures.
To investigate the function of hedgehog signalling in regulating suture MSCs, we generated Gli1-Cre ERT 2 ;Smoothened flox/flox mice (Smo ICKO) and induced them at one month age. Blockage of the Hh pathway had no obvious impact on suture patency in these mice (Fig. 5g-l) . Gli1+ cells could still give rise to periosteum, dura and osteocytes ( Supplementary Fig. 5p ). However, all of the craniofacial bones exhibited severe osteoporosis and reduced bone volume eight months after induction (Fig. 5g-l) . We also examined the continuously growing incisors in Smo ICKO mice. We found that significant phenotypes appeared much sooner after induction in the incisors. Although the incisors continued growing, they showed significantly reduced odontogenesis and amelogenesis, disrupted odontoblast organization and severe periodontal ligament defects ( Supplementary Fig. 5a-l) . Proliferation analysis indicated that loss of hedgehog signalling had no significant effects on the ratio of proliferating cells in either the incisor or sagittal suture ( Supplementary Fig. 5m,n) . No apoptotic cells were detectable in the incisor or sagittal suture of control or Smo ICKO mice ( Supplementary  Fig. 5o ). To investigate the effects of hedgehog signalling, we collected suture mesenchymal cells from one-month-old mice and treated them with IHH or hedgehog inhibitor GDC0449. IHH treatment (500 ng ml Values are plotted as mean ± s.e.m. * , P < 0.05. Student t-test analyses were performed to compare the skull length (P = 0.02, n = 5 skulls), skull width (P = 0.01, n = 5 skulls), maxillary bone volume (P = 0.02, n = 5 skulls), palatal bone volume (P = 0.02, n = 5 skulls) and sphenoid bone volume (P = 0.01, n = 5 skulls). (s,t) MicroCT images of one-month-old control and DTA mice injured five days after induction. Arrows in samples collected one month later indicate complete healing in the control sample and incomplete healing in the DTA sample. Scale bars in n-q, 200 µm; other scale bars, 1 mm.
( Supplementary Fig. 5q-s) . Neither treatment had a significant effect on proliferation or apoptosis ( Supplementary Fig. 5t ). Three weeks after treatment, osteogenic activity was increased in IHH-treated cells and decreased in GDC0449-treated cells ( Supplementary Fig. 5u-w) . Real-time PCR also confirmed the opposing effects of IHH and GDC0449 on regulating the osteogenic differentiation ability of suture MSCs ( Supplementary Fig. 5x ). These results indicate that hedgehog signalling is important for regulating the differentiation of Gli1+ MSCs but not for their maintenance.
Gli1+ cell ablation leads to craniosynostosis, skull growth arrest, osteoporosis and compromised injury repair
To investigate whether Gli1+ stem cells are indispensable for homeostasis and injury repair, we generated Gli1-Cre ERT 2 ;DTA flox/flox mice (DTA) and induced them with tamoxifen at one month of age. Theoretically, induction should cause ablation of all Gli1+ cells.
We discovered that some Gli1-expressing cells survived the ablation, indicating that the DTA model we generated was not entirely efficient ( Supplementary Fig. 5z ). However, even this incomplete Gli1+ cell ablation led to striking craniofacial phenotypes. One month after induction, most sutures remain patent except the coronal and frontalpremaxilla sutures, suggesting that these two sutures are more sensitive to Gli1+ cell ablation (Fig. 6b) . Two months after induction, the general body size of the DTA mice was significantly smaller than that of controls of the same age and was comparable to one-monthold control mice, indicating the arrest of body growth after the ablation ( Supplementary Fig. 5y ). In addition, all of the craniofacial sutures had fused (Fig. 6c-g ). The anterior-posterior length and the width of the skull of the DTA mice were reduced by ∼20% and 15%, respectively (Fig. 6r) . All of the craniofacial bones exhibited severe osteoporosis (Fig. 6h-m) . Quantitative analysis of the volume of the maxillary bone, palatal bone and basosphenoid bone showed that all were reduced by more than 40% (Fig. 6r) . Haematoxylin and eosin (HE) staining confirmed the disappearance of the sagittal suture and coronal suture as well as the presence of porous bone structure (Fig. 6n-q) .
To evaluate the impact of Gli1+ cell ablation on injury repair, we injured the calvarial bone of DTA mutants and controls one month after their induction. Although inspection of the control samples revealed that they had healed completely after one month, the injury sites in the DTA mutant calvarial bones remained open, indicating a compromised healing process (Fig. 6s,t) .
The stem cell population is diminished in the sutures of Twist1 +/− mice with craniosynostosis Our identification of Gli1+ stem cells in the craniofacial sutures and the craniosynostosis phenotype observed after Gli1+ cell ablation suggest that premature loss of stem cells from the suture causes the premature suture fusion observed in craniosynostosis.
To test this hypothesis, we generated Twist1 +/− ;Gli1-LacZ +/− mice. Twist1 +/− is a widely accepted synostosis mouse model and the corresponding mutation in humans is linked to Saethre-Chotzen syndrome, which is the most common craniosynostosis disorder [35] [36] [37] [38] . Whole-mount LacZ staining of mice at one month of age indicated that the number of Gli1+ cells was significantly reduced (Fig. 7a-f ). Gli1+ cells were not detectable in regions of fused coronal suture (Fig. 7f-b ) . Even in sutures of Twist1 +/− mutants that remain patent, such as the coronal, lambdoid and sagittal sutures, the number of Gli1+ cells was reduced, and the reduction was more severe in the synostosed sutures (Fig. 7d-g ).
Next, we isolated suture mesenchymal cells from Twist1 +/− mutants and littermate control calvarial bones. In vitro cultures indicated that both clone formation efficiency and clone size of Twist1 +/− suture mesenchymal cells were reduced by over 50% (Fig. 7h) . Synostosis occurs between P9 and P13 in Twist1 +/− mice 37, [39] [40] [41] . To investigate whether loss of Gli1+ cells occurs before suture closure, we examined Gli1 expression at P1, P7 and P14. Wholemount LacZ staining indicated that Gli1+ cells in Twist1 +/− mice at P1 did not differ significantly from controls in their number or distribution pattern (Fig. 7i,l) . At P7 and P14, Gli1+ cells were significantly reduced in all sutures of Twist1 +/− mice (Fig. 7j,k,m,n) . To investigate the reduction in Gli1+ cells, we performed proliferation and apoptosis assays. EdU incorporation assays in P5 pups indicated that the number of proliferating cells in the sutures of Twist1 +/− mice was reduced by nearly 50% (Fig. 7o,q) . At P5, discontinuous apoptotic cell foci were detectable in the coronal and lambdoid sutures of Twist1 +/− mice, whereas no apoptotic cells were detectable in the sagittal sutures (Fig. 7p ).
DISCUSSION
Our study shows that Gli1+ cells in the suture mesenchyme are stem cells for craniofacial bones. They give rise to the osteogenic front, periosteum, dura and craniofacial bones (Supplementary Fig. 6a ). The Gli1+ population provides an indispensable stem cell source supporting craniofacial bone turnover and injury repair in the adult. These Gli1+ cells can be considered osteogenic stem cells because they largely or perhaps exclusively give rise to bone tissue; craniofacial bones contain few chondrocytes except in the basal skull and nasal septum. The periosteum and dura are mainly comprised of committed osteogenic progenitors, as evidenced by their high expression of differentiation markers, and these tissues derive from the suture (Supplementary Fig. 6a ).
Gli1 is specifically expressed within the suture mesenchyme but not in haematopoietic cells or endothelium 26 . Gli1+ cells in the suture mesenchyme are not perivascular, as tendon stem cells are 42, 43 . IHH secreted from progeny cells in the osteogenic front regulates the differentiation of Gli1+ MSCs within the suture ( Supplementary  Fig. 6b ). Hedgehog signalling is not critical for stem cell maintenance, as previously shown in incisors and long bones 26, 44, 45 . Craniofacial bones contain limited bone marrow space and the Gli1+ cells within the marrow also contribute to new bone formation. Their contribution to craniofacial bones is less significant than that of the suture MSCs based on our transplantation experiments and their small population size.
Ablation of Gli1+ cells leads to fusion of all craniofacial sutures in adult mice. The fusion might be due to the loss of a constant stem cell supply that is needed to produce sufficient undifferentiated mesenchymal cells to keep the suture patent. Combining the craniosynostosis phenotypes after Gli1+ cell ablation with the reduced Gli1+ cell numbers observed in Twist1 +/− sutures, we propose a mechanism for explaining craniosynostosis, namely that premature loss of MSCs from a craniofacial suture can contribute to craniosynostosis. This concept of the disease will have a profound impact on our approach to diagnosis, prevention and treatment of craniosynostosis. Twist1 is specifically expressed in the suture mesenchyme after E16 (ref. 41) . Twist1 +/− mice exhibit increased apoptosis and reduced proliferation within the suture mesenchyme 46, 47 , probably resulting in the reduced Gli1+ cells that we reported. It seems that there is a threshold number of suture stem cells required for maintaining suture patency. This may help to explain the often-asymmetrical nature of craniosynostosis.
In summary, we have identified Gli1+ cells within the suture mesenchyme as an indispensable MSC population supporting craniofacial bone turnover and injury healing. These stem cells are not associated with vasculature and are regulated by IHH secreted from the osteogenic front. Gli1+ cells in the suture mesenchyme do not express conventional MSC markers in vivo; their derivatives in vitro, however, express all of these markers and behave like typical MSCs (refs 26,48-50) . Collectively, the results of our study will have a profound impact on the understanding of craniofacial bones as well as the pathogenesis of craniosynostosis and other craniofacial disorders.
METHODS
Methods and any associated references are available in the online version of the paper.
Note: Supplementary Information is available in the online version of the paper
Histology. Samples were dissected under a stereomicroscope (Leica L2) and fixed in 4% paraformaldehyde overnight at room temperature, and then decalcified in 20% EDTA for 14 days. Decalcified samples were dehydrated in 60% sucrose/PBS solution overnight at room temperature. Samples were embedded in an OCT compound (Tissue-Tek, Sakura) under a stereomicroscope and transferred onto dry ice to solidify. Embedded samples were cryosectioned at 16 µm thickness using a cryostat (Leica CM1850). Images were captured using a fluorescence microscope (Leica DMI 3000B) with filter settings for DAPI/FITC/TRITC and merged with Adobe Photoshop CS6. Confocal images were acquired using Leica LAS AF software (Leica) with lasers and corresponding band-pass filters for DAPI (Ex. 405 nm, BP410-490), GFP (Ex. 488 nm, BP450-550), tdTomato (Ex. 543 nm, BP550-595) and Alexa633 (Ex. 633 nm, LP650). Adobe Photoshop software was used to capture and align images. Representative images from at least three independent samples or experiments are shown in the figures (see Reproducibility of experiments).
Tamoxifen administration. Tamoxifen (Sigma T5648) was suspended in corn oil (Sigma C8267) at 20 mg ml −1 and injected intraperitoneally (i.p.) at a dosage of 10 mg daily for 4 days. Suture transplantation. Our surgical protocol was adapted from a previous study 51 . After euthanizing donor mice, a section of sagittal suture 2 mm in length was dissected together with ∼0.5 mm of abutting parietal bone on each side. The periosteum and dura were either preserved or carefully removed with a scalpel depending on the experimental design. Each transplant was imaged under a microscope before transplantation to measure its initial size. Nude mice were used as the recipient mice. Under general anaesthesia, a midline sagittal skin incision was made and a scalp flap was elevated to reveal the calvaria. The periosteum was retracted over the left and right parietal bones from the mid-sagittal incision to expose the underlying bone. A 4 mm 2 defect was made in the centre of the left or right parietal bone of the host using a hand-held drill (NSK Z500). Extreme care was taken not to damage the underlying dura. Donor transplants were placed over the recipient calvarial window with the dura side facing the brain. No additional fixation was necessary. The host skin was sutured using 4.0 nylon stitches.
Suture and calvarial bone injury assays. In the suture injury assay, a midline sagittal incision was made under general anaesthesia and the scalp was revealed to expose the sagittal suture. A 25 gauge needle was used to scratch the sagittal suture surface. The scalp was then sutured together with 4.0 nylon stitches. In the calvarial bone injury assay, the scalp was cut and elevated to expose the parietal bones. A dental round burr was used to drill a hole of ∼1 mm diameter 2 mm away from the sagittal suture in the parietal bone. The scalp was then sutured with silk stitches.
Statistical analysis. SPSS software version 13.0 was used for statistical analysis.
Significance was assessed using independent two-tailed Student's t-tests or analysis of variance (ANOVA). A P value less than 0.05 was considered significant. No statistical method was used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. Real-time PCR. The mRNA levels of ALPase, Runx2, Sp7 and osteocalcin were analysed by real-time quantitative RT-PCR. Cells were collected from the culture dishes and total RNA was extracted using the RNeasy Mini Kit (Qiagen 74104). One microgram of total RNA was reverse-transcribed with oligo-dT primers into cDNAs using SuperScript III First-Strand (Invitrogen no. 18080-051). Real-time PCR was performed using a SYBR super mix kit (Bio-Rad no. 170-8880) as reported previously 52 . For thermal cycling, a CFX96 Real-Time System (Bio-Rad iCycler) was used at 95 • C for 10 min, then 40 cycles of 95 • C for 10 s and 55 • C for 30 s. The relative amount of each mRNA transcript was calculated on the basis of a standard curve of cycle thresholds and normalized to β-actin expression as the internal control. Real-time PCR was performed in triplicate for each sample. All experiments were repeated three times. The primers are as follows: mouse β-actin, 5 -GCAAGTGCTTCTAGGCGGAC-3 and 5 -AAGAAAGGGTGTAAAACGCAG C-3 ; mouse ALPase, 5 -GCTGATCATTCCCACGTTTT-3 and 5 -CTGGGCCT GGTAGTTGTTGT-3 ; mouse Runx2, 5 -CCCAGCCACCTTTACCTACA-3 and 5 -TATGGAGTGCTGCTGGTCTG-3 ; mouse Sp7, 5 -AGTTCACCTGCCTGCTC TGT-3 and 5 -GGAGCTGGAGACCTTCCTCT-3 ; mouse osteocalcin, 5 -AAGCA GGAGGGCAATAAGGT-3 and 5 -ACTTGCAGGGCAGAGAGAGA-3 .
X-gal staining. Samples from mice were fixed in 0.2% glutaraldehyde overnight and then decalcified with 20% EDTA for 2 weeks. Frozen sections were cut of 12 µm thickness. Sections or cultured cells were stained with X-gal (C 14 H 15 BrClNO 6 , USB) overnight at 37 • C according to a standard procedure.
Suture mesenchymal cell mass culture, clonal culture and multipotential differentiation. Our suture mesenchymal cell culture procedure was adopted from previous studies 31, 53 . After removing the periosteum and dura, the sagittal suture was excised along with ∼0.5 mm of abutting parietal bone on each side. The suture tissue was minced into tiny pieces and the tissue blocks were transferred into a T25 culture flask (Corning CLS430639) and incubated with αMEM+20% FBS (Invitrogen 10437-085) at 37 • C in regular atmospheric conditions. For clonal culture of suture mesenchymal cells, 1,000 cells from the sagittal suture mesenchyme were plated in a T75 culture flask (Corning CLS430641) coated with fibronectin (Invitrogen 33010-018) and incubated with αMEM+20% FBS (Invitrogen 10437-085) at 37 • C under hypoxic conditions (5% O 2 , 5% CO 2 , balanced with Nitrogen). Clones could be detected ∼10 days after plating. Single clones were circled with a cloning ring and digested with TrypLE (Invitrogen 12605). Cells were divided and plated into three wells in a fibronectin-coated 24-well culture plate (Corning CLS3527) and cultured under hypoxic conditions until confluence. Osteogenic, adipogenic or chondrogenic differentiation was then performed as previously described 54 . . Mouse experiments were approved by the University of Southern California Institutional Animal Care and Use Committee and performed following the regulations for animal experiments at University of Southern California. All mice were housed in a pathogen-free condition and analysed in a mixed background. Mice were identified by ear tags. Tail biopsies of mice were lysed by incubating the tail sample at 55 • C overnight in DirectPCR tail solution (Viagen 102-T) followed by 85 • C heat inactivation for 30 min and used for PCR-based genotyping (GoTaq Green Master Mix, Promega, and C1000 Touch Cycler, Bio-rad). Mice were euthanized by carbon dioxide or decapitation. All mice were used for analysis regardless of sex.
Flow
For the experiments in Fig. 1a -p, male Gli1-LacZ mice were mated to female CD1 mice (>8 weeks old, Jackson Lab) and vaginal plugs were checked the next morning. Newborn pups were counted as P0. Mice at indicated ages were collected and genotyped.
For experiments in Fig. 2a -i, Gli1-Cre ERT 2 ;ROSA26 LoxP−STOP−LoxP−ZsGreen1 mice of mixed background were injected with tamoxifen at one month of age. Samples were collected at indicated time points after induction.
For the experiments in Fig. 3a -d, Gli1-LacZ or Gli1-Cre ERT 2 ; ROSA26 LoxP−STOP−LoxP−ZsGreen1 mice of mixed background were injured at one month age. For experiments in Fig. 3e-i , calvaria or suture transplants were obtained from one-month-old donor mice and transplanted into one-month-old nude mice.
For experiments in Fig. 4a-f , one-month-old Gli1-LacZ mice were used for analysis. For experiments in Fig. 4g -l, one-month-old Gli1-Cre ERT 2 ; ROSA26 LoxP−STOP−LoxP−tdTomato mice were used for cell culture. For experiments in Fig. 5a-f , one-month-old mice were used for analysis. For experiments in Fig. 5g-l , one-month-old Gli1-Cre ERT 2 ;Smo flox/flox mice were induced with tamoxifen and samples were collected at indicated time points after induction.
For experiments in Fig. 6a -t, Gli1-CreERT2;ROSA26 LoxP−STOP−LoxP−DTA or DTA flox/flox mice were induced with tamoxifen at one month of age. Samples were collected at indicated time points after induction.
For experiments in Fig. 7a -p, male Twist1+/− mice were mated with female Gli1-LacZ+/− mice to generate Twist1+/−;Gli1-LacZ+/− mice. Samples were collected at indicated ages.
For experiments in Supplementary Figs 1d-f and 2a-o,q, mice of indicated genotypes were collected at one month of age. For experiments in Supplementary  Fig. 2p , Gli1-LacZ +/− pups of P8 were collected for experiments.
For experiments in Supplementary Fig. 3a -o , one-month-old Gli1-Cre ERT 2 ;ROSA26 LoxP−STOP−LoxP−tdTomato mice were induced with tamoxifen and samples were collected at indicated time points after induction.
For experiments in Supplementary Fig. 4a ,b, one-month-old Gli1-LacZ mice were used for analysis. For experiments in Supplementary Fig. 4c,d , one-monthold Gli1-Cre ERT 2 ;ROSA26 LoxP−STOP−LoxP−tdTomato mice were induced and samples were collected at indicated time points.
For experiments in Supplementary Fig. 5a -p, one-month-old Gli1-Cre ERT 2 ; Smo flox/flox mice were induced with tamoxifen and samples were collected at indicated time points after induction. For experiments in Supplementary Fig. 5q-x , onemonth-old Gli1-LacZ mice were used for collecting suture MSCs. For experiments in Supplementary Fig. 5y , squamous-zygomatic (e, e'), maxilla-premaxilla (f, f'), frontal-maxilla (g, g'), frontal-squamous (h, h'), frontal-premaxilla (i, i'), nasal-frontal (j, j'), intermaxilla (k, k'), basosphenoid-squamous (l, l') and basosphenoid-frontal (m, m'). (n, n', o') Immunostaining of Sp7 or Runx2 in the osteogenic front of Gli1-Cre ERT2 ;R26Tdtomato fl mice. Arrowheads indicate Sp7+ or Runx2+ cells in the osteogenic front. Dotted lines outline the bone surfaces. Scale bars, 100µm.
